Recent quarterly results show that the original 10% dividend really was unsustainable.
Energy Transfer would love to get out of its merger with Williams. If it takes a gentler approach, its shares could gain.
GoPro said it swung to a deep loss in the first quarter, spotlighting the uphill battle the action-camera maker faces in broadening its customer base, though sales beat market expectations.
Valeant Pharmaceuticals International Inc., which has come under heavy fire from politicians because of dramatic price increases for its drugs, said it had formed a committee that will be responsible for those prices going forward.
Apple Inc. and SAP SE said they would cooperate to help developers create iPad and iPhone apps tapping the German software giant’s database services and analytics.
GM and Lyft will begin testing self-driving Chevrolet Bolt electric taxis on public roads within a year, as the companies seek to fight off Silicon Valley giants amid a reshaping auto industry.
Price increases of brand-name biotech drugs are diminishing expected savings from rival versions, called biosimilars, adding to pressure on overall health costs.
For all of BT’s eye-catching pledges, investment looks low by European standards.
The number of Americans filing for new unemployment benefits jumped for the second week running but remained at a low level consistent with a strengthening job market.
Alibaba’s main e-commerce businesses continued to excel last quarter. But myriad investments in new areas dragged down results.